{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T20:11:21Z","timestamp":1794255081897,"version":"4.9.0"},"reference-count":20,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2022,5,11]],"date-time":"2022-05-11T00:00:00Z","timestamp":1652227200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,1,3]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n               <jats:p>Castleman\u2019s disease (CD) is a rare, systemic disease with histopathological features of angiofollicular lymph node hyperplasia. In the literature, there are case-level reports that mimic or coexist with systemic lupus erythematosus (SLE) clinically and in the laboratory. Is this condition two separate diseases or is it an imitation of each other? A 73-year-old female patient was admitted to our clinic with arthritis, lymphadenopathy, fever, weight loss, and malar rash. He had a history of idiopathic thrombocytopenic purpura and thrombosis in the right leg tibialis posterior and dorsalis pedis arteries. Excisional lymphadenopathy biopsy indicated a diagnosis of hyaline-vascular-type CD. She had anti-nuclear antibody &amp;gt;1\/80 homogeneous pattern, anti-double stranded DNA (anti-dsDNA), Anti-Smith (Sm) antibody positivity, hypocomplementemia (C3 and C4), pleural effusion, and pericardial effusion. For this reason, the classification criteria of the European League Against Rheumatism\/American College of Rheumatology were studied. Clinical findings, idiopathic thrombocytopenic purpura history, antibody positivity, malar rash, and arthritis led us to the diagnosis of SLE. She was treated with 1\u2009mg\/kg\/day prednisolone and hydroxychloroquine 200\u2009mg 2\u2009\u00d7\u20091. Azathioprine 2.5\u2009mg\/kg daily was added to the patient whose complaints did not improve. In the follow-ups, she completely recovered clinically and laboratory. SLE and CD are systemic diseases that overlap in many ways. The literature review shows that these two diseases may mimic each other or may coexist. This situation may be a reflection of a pathophysiological process that has not yet been clarified. This confusing process also affects the treatment decision. This confusing process also affects the treatment decision.<\/jats:p>","DOI":"10.1093\/mrcr\/rxac045","type":"journal-article","created":{"date-parts":[[2022,5,11]],"date-time":"2022-05-11T04:14:07Z","timestamp":1652242447000},"page":"271-275","source":"Crossref","is-referenced-by-count":5,"title":["Mimic or coincidentally? TAFRO syndrome and systemic lupus erythematosus: A case-based review"],"prefix":"10.1093","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9028-9930","authenticated-orcid":false,"given":"Burak","family":"Okyar","sequence":"first","affiliation":[{"name":"Division of Rheumatology, Department of Internal Medicine, Kahramanmara\u015f S\u00fct\u00e7\u00fc \u0130mam University Faculty of Medicine , Oniki\u015fubat\/Kahramanmara\u015f, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bekir","family":"Torun","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Department of Internal Medicine, Kahramanmara\u015f S\u00fct\u00e7\u00fc \u0130mam University Faculty of Medicine , Oniki\u015fubat\/Kahramanmara\u015f, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esen Saba","family":"\u00d6ktem","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Department of Internal Medicine, Kahramanmara\u015f S\u00fct\u00e7\u00fc \u0130mam University Faculty of Medicine , Oniki\u015fubat\/Kahramanmara\u015f, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdulkadir Yasir","family":"Bahar","sequence":"additional","affiliation":[{"name":"Department of Pathology, Kahramanmara\u015f S\u00fct\u00e7\u00fc \u0130mam University Faculty of Medicine , Oniki\u015fubat\/Kahramanmara\u015f, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatih","family":"Y\u0131ld\u0131z","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Department of Internal Medicine, Kahramanmara\u015f S\u00fct\u00e7\u00fc \u0130mam University Faculty of Medicine , Oniki\u015fubat\/Kahramanmara\u015f, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00f6zde Y\u0131ld\u0131r\u0131m","family":"\u00c7etin","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Department of Internal Medicine, Kahramanmara\u015f S\u00fct\u00e7\u00fc \u0130mam University Faculty of Medicine , Oniki\u015fubat\/Kahramanmara\u015f, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2022,5,11]]},"reference":[{"key":"2023010315512073200_R1","doi-asserted-by":"crossref","first-page":"2107","DOI":"10.1007\/s00432-020-03494-2","article-title":"Clinical characteristics and immunological abnormalities of Castleman disease complicated with autoimmune diseases","volume":"147","author":"Sun","year":"2021","journal-title":"J Cancer Res Clin Oncol"},{"key":"2023010315512073200_R2","doi-asserted-by":"crossref","DOI":"10.1186\/2162-3619-4-3","article-title":"Successful treatment of a Caucasian case of multifocal Castleman\u2019s disease with TAFRO syndrome with a pathophysiology targeted therapy - a case report","volume":"4","author":"Tedesco","year":"2015","journal-title":"Exp Hematol Oncol"},{"key":"2023010315512073200_R3","doi-asserted-by":"crossref","first-page":"4859","DOI":"10.21037\/jtd.2019.10.73","article-title":"Clinicopathologica comparison and therapeutic approach to Castleman disease\u2014a case-based review","volume":"11","author":"Wojty\u015b","year":"2019","journal-title":"J Thorac Dis"},{"key":"2023010315512073200_R4","article-title":"Idiopathic multicentric Castleman\u2019s disease: a systematic literature review","volume":"3","author":"Liu","year":"2016","journal-title":"Lancet Hematol"},{"key":"2023010315512073200_R5","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1177\/09612033211021161","article-title":"Immune thrombocytopenia and COVID-19: case report and review of literature","volume":"30","author":"Alonso-Beat","year":"2021","journal-title":"Lupus"},{"key":"2023010315512073200_R6","doi-asserted-by":"crossref","first-page":"819","DOI":"10.14740\/jocmr2717w","article-title":"Generalized lymphadenopathy as presenting feature of systemic lupus erythematosus: case report and review of the literature","volume":"8","author":"Afzal","year":"2016","journal-title":"Clin Med Res"},{"key":"2023010315512073200_R7","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.prp.2007.03.002","article-title":"Histological diversity of reactive and atypical proliferative lymph node lesions in systemic lupus erythematosus patients","volume":"203","author":"Kojima","year":"2007","journal-title":"Pathol Res Pract"},{"key":"2023010315512073200_R8","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1007\/s00296-020-04684-4","article-title":"Systemic lupus erythematosus complicated with Castleman disease: a case\u2013based review","volume":"41","author":"Demirkan","year":"2021","journal-title":"Rheumatol Int"},{"key":"2023010315512073200_R9","article-title":"A case of Castleman disease: a diagnostic dilemma","volume":"13","author":"Anwar","journal-title":"Cureus"},{"key":"2023010315512073200_R10","doi-asserted-by":"crossref","DOI":"10.1186\/s13317-020-00138-w","article-title":"Castleman disease and SLE in a G6PD\u2013deficient Marfan patient: a case report and literature review","volume":"11","author":"Alhoulaiby","year":"2020","journal-title":"Autoimmun Highlights"},{"key":"2023010315512073200_R11","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1179\/acb.2004.023","article-title":"Atypical systemic lupus erythematosus or Castleman\u2019s disease","volume":"59","author":"Van de Voorde","year":"2004","journal-title":"Acta Clin Belg"},{"key":"2023010315512073200_R12","doi-asserted-by":"crossref","first-page":"143","DOI":"10.5606\/tjr.2013.3108","article-title":"Castleman\u2019s disease combined with the development of systemic lupus erythematosus","volume":"28","author":"Ying","year":"2013","journal-title":"Turk J Rheumatol"},{"key":"2023010315512073200_R13","first-page":"1255","article-title":"Clonal multicentric Castleman\u2019s disease with increased free kappa light chains in a patient with systemic lupus erythematosus","volume":"93","author":"Oyaert","journal-title":"Ann Hematol"},{"key":"2023010315512073200_R14","doi-asserted-by":"crossref","first-page":"2551","DOI":"10.4103\/0366-6999.164989","article-title":"Successful treatment with rituximab in a patient with Castleman\u2019s disease complicated by systemic lupus erythematosus and severe autoimmune thrombocytopenia","volume":"128","author":"Zhang","year":"2015","journal-title":"Chin Med J"},{"key":"2023010315512073200_R15","first-page":"265","article-title":"Association of macrophage activating syndrome with Castleman\u2019s syndrome in systemic lupus erythematosus","volume":"11","author":"Shariatpanahi","year":"2016","journal-title":"Iran J Pathol"},{"key":"2023010315512073200_R16","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.1007\/s00296-010-1451-0","article-title":"A case report of systemic lupus erythematosus combined with Castleman\u2019s disease and literature review","volume":"32","author":"Xia","year":"2012","journal-title":"Rheumatol Int"},{"key":"2023010315512073200_R17","doi-asserted-by":"crossref","first-page":"e20","DOI":"10.1111\/j.1756-185X.2010.01476.x","article-title":"Pararenal retroperitoneal Castleman\u2019s disease mimicking systemic lupus erythematosus","volume":"13","author":"KIM","year":"2010","journal-title":"Int J Rheum Dis"},{"key":"2023010315512073200_R18","article-title":"Castleman disease mimicking systemic lupus erythematosus","volume":"97","author":"Wang","year":"2018","journal-title":"Medicine"},{"key":"2023010315512073200_R19","first-page":"314","article-title":"A rare lymphoproliferative disease: Castleman disease","volume":"38","author":"G\u00fcnd\u00fcz","year":"2021","journal-title":"Turk J Hematol"},{"key":"2023010315512073200_R20","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1177\/0961203317725589","article-title":"Characterization of patients with systemic lupus erythematosus who meet the diagnostic criteria for TAFRO syndrome","volume":"27","author":"Hasegawa","year":"2018","journal-title":"Lupus"}],"container-title":["Modern Rheumatology Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/mrcr\/advance-article-pdf\/doi\/10.1093\/mrcr\/rxac045\/44204735\/rxac045.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/mrcr\/article-pdf\/7\/1\/271\/48482100\/rxac045.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/mrcr\/article-pdf\/7\/1\/271\/48482100\/rxac045.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,3]],"date-time":"2023-01-03T15:51:50Z","timestamp":1672761110000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/mrcr\/article\/7\/1\/271\/6583475"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,11]]},"references-count":20,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,5,11]]},"published-print":{"date-parts":[[2023,1,3]]}},"URL":"https:\/\/doi.org\/10.1093\/mrcr\/rxac045","relation":{},"ISSN":["2472-5625"],"issn-type":[{"value":"2472-5625","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2023,1,1]]},"published":{"date-parts":[[2022,5,11]]}}}